Faculty: Charles Paul | Code: MD3761
Too often, companies wait until the Biologics License Application (BLA) stage to think about their Target Product Profile (TPP)—by then, it’s lost much of its strategic value. The TPP is not just another set of specifications or acceptance criteria. According to FDA guidance, it's a strategic development tool meant to guide smarter decisions throughout the drug development process. Without a well-structured TPP, teams risk wasting time and resources. For instance, an analytical team working without a clear understanding of the product may develop methods that miss the mark entirely. A solid TPP prevents such missteps by aligning development with the end goals from the outset.
Imagine a neighbor asking how long to bake a dessert. You’d need more details—what dessert, how big, what temperature? Similarly, the TPP gives the FDA and development teams critical context about the product, making responses and evaluations more meaningful and efficient.
In parallel, the digital transformation of medical devices is bringing tremendous innovation to healthcare—but also serious cybersecurity risks. Modern devices rely heavily on interconnected software, wireless communication, and long operational lifespans. Without regular updates or strong safeguards, they become easy targets for cyberattacks. These threats endanger not only sensitive data but also patient safety.
To address these concerns, regulators are pushing for stronger cybersecurity standards. This webinar dives deep into the risks facing medical devices, the evolving regulatory environment, and real-world case studies of breaches and recovery. Participants will explore proven strategies for identifying vulnerabilities, complying with regulations, and protecting devices throughout their lifecycle. The session also looks ahead to emerging technologies, offering a forward-thinking approach to securing the future of healthcare innovation.
WHY SHOULD YOU ATTEND
With cyber threats on the rise, medical devices have become prime targets for attacks, exposing patient data and critical healthcare infrastructure to potential breaches. Failure to comply with FDA, ISO, and global cybersecurity regulations can result in product recalls, legal liabilities, and reputational damage.
This training will provide:
Whether you're in medical device manufacturing, IT security, regulatory compliance, or healthcare operations, this webinar will equip you with the tools to enhance cybersecurity resilience and regulatory readiness.
AREAS COVERED
WHO SHOULD ATTEND
![]() | Charles Paul is an instructional designer and management consultant with over 30 years experience providing training and consulting services to regulated industries. He has installed quality systems and designed and developed GMP and operational documentation and training programs for foods and beverage, pharmaceuticals, biotech, cosmetics, and consumer product OTC industries. |